Etofibrate


Concise Prescribing Info
Indications/Uses
Hyperlipidaemias.
Dosage/Direction for Use
Adult : PO 500 mg/day.
Dosage Details
Oral
Hyperlipidaemias
Adult: 500 mg daily.
Administration
Should be taken with food. Best taken after the evening meal.
Contraindications
Liver diseases; gallbladder diseases; severe renal insufficiency; decompensated heart failure; acute cardiac infarct; acute bleedings; pregnancy; lactation.
Special Precautions
Perform regular liver function tests. May increase the risk of cholelithiasis. Regular monitoring of INR when used with coumarin-type anticoagulants.
Adverse Reactions
Flush syndrome and reactions to flush; GI disorders.
Drug Interactions
Anticoagulants; sulfonylureas; HMG-CoA reductase inhibitors; coronary vasodilating drugs. Increased risk of nephrotoxicity with cyclosporine.
Action
Description: Etofibrate, a clofibrate and nicotinic acid derivative, is a lipid-regulating drug.
Disclaimer: This information is independently developed by MIMS based on Etofibrate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in